Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma.

Olaverria Salavaggione, Gonzalo N

Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma. [electronic resource] - Melanoma research 10 2018 - 390-397 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1473-5636

10.1097/CMR.0000000000000474 doi


Cell Line, Tumor
Cyclopentanes--pharmacology
Enzyme Inhibitors--pharmacology
Humans
Melanoma--drug therapy
Pyrimidines--pharmacology
Skin Neoplasms--drug therapy
Survival Rate